tiprankstipranks
Trending News
More News >
AbbVie (ABBV)
NYSE:ABBV
US Market

AbbVie (ABBV) Ratios

Compare
23,514 Followers

AbbVie Ratios

ABBV's free cash flow for Q3 2025 was $0.79. For the 2025 fiscal year, ABBV's free cash flow was decreased by $ and operating cash flow was $0.09. See a summary of the company’s cash flow.
Ratios
TTM
Dec 24Dec 23Dec 22Dec 21
Liquidity Ratios
Current Ratio
0.72 0.66 0.87 0.96 0.79
Quick Ratio
0.60 0.55 0.76 0.84 0.70
Cash Ratio
0.14 0.14 0.34 0.31 0.28
Solvency Ratio
0.08 0.10 0.11 0.17 0.15
Operating Cash Flow Ratio
0.53 0.49 0.60 0.84 0.65
Short-Term Operating Cash Flow Coverage
3.61 2.76 3.18 6.03 1.82
Net Current Asset Value
$ -107.96B$ -106.22B$ -91.31B$ -93.06B$ -103.17B
Leverage Ratios
Debt-to-Assets Ratio
0.51 0.50 0.44 0.46 0.52
Debt-to-Equity Ratio
-26.02 20.40 5.73 3.67 4.98
Debt-to-Capital Ratio
1.04 0.95 0.85 0.79 0.83
Long-Term Debt-to-Capital Ratio
1.04 0.95 0.83 0.77 0.81
Financial Leverage Ratio
-50.68 40.65 13.00 8.04 9.51
Debt Service Coverage Ratio
1.57 1.61 1.69 4.68 1.80
Interest Coverage Ratio
4.63 3.25 5.74 8.12 7.40
Debt to Market Cap
0.18 0.21 0.22 0.22 0.32
Interest Debt Per Share
40.38 39.94 34.85 36.99 44.69
Net Debt to EBITDA
4.96 4.18 2.69 1.72 2.37
Profitability Margins
Gross Profit Margin
76.21%69.99%62.42%70.00%68.96%
EBIT Margin
7.49%11.58%15.85%27.06%27.42%
EBITDA Margin
21.33%26.47%31.86%54.13%50.32%
Operating Profit Margin
21.79%16.22%23.49%31.21%31.89%
Pretax Profit Margin
2.78%6.60%11.51%23.21%23.11%
Net Profit Margin
4.01%7.59%8.95%20.39%20.54%
Continuous Operations Profit Margin
4.02%7.61%8.97%20.40%20.55%
Net Income Per EBT
144.22%115.12%77.81%87.82%88.86%
EBT Per EBIT
12.77%40.67%48.99%74.39%72.47%
Return on Assets (ROA)
1.79%3.17%3.61%8.53%7.88%
Return on Equity (ROE)
498.75%128.66%46.94%68.60%74.91%
Return on Capital Employed (ROCE)
13.75%9.48%13.17%16.58%16.10%
Return on Invested Capital (ROIC)
18.70%8.85%9.56%14.04%12.87%
Return on Tangible Assets
5.45%10.66%10.39%30.19%30.22%
Earnings Yield
0.61%1.36%1.77%4.14%4.82%
Efficiency Ratios
Receivables Turnover
4.67 5.16 4.87 5.16 5.63
Payables Turnover
0.43 5.74 5.54 5.94 6.05
Inventory Turnover
2.87 4.04 4.98 4.87 5.58
Fixed Asset Turnover
10.88 10.97 10.89 11.76 11.00
Asset Turnover
0.45 0.42 0.40 0.42 0.38
Working Capital Turnover Ratio
-5.59 -6.26 -18.37 -13.92 -9.56
Cash Conversion Cycle
-652.94 97.43 82.31 84.28 69.95
Days of Sales Outstanding
78.14 70.75 74.96 70.76 64.80
Days of Inventory Outstanding
127.01 90.28 73.29 75.02 65.44
Days of Payables Outstanding
858.09 63.59 65.94 61.50 60.30
Operating Cycle
205.15 161.02 148.24 145.77 130.24
Cash Flow Ratios
Operating Cash Flow Per Share
11.77 10.63 12.92 14.08 12.87
Free Cash Flow Per Share
11.61 10.08 12.48 13.69 12.42
CapEx Per Share
0.16 0.55 0.44 0.39 0.44
Free Cash Flow to Operating Cash Flow
0.99 0.95 0.97 0.97 0.97
Dividend Paid and CapEx Coverage Ratio
1.77 1.57 2.02 2.32 2.27
Capital Expenditure Coverage Ratio
71.68 19.31 29.39 35.89 28.94
Operating Cash Flow Coverage Ratio
0.30 0.28 0.38 0.39 0.30
Operating Cash Flow to Sales Ratio
0.35 0.33 0.42 0.43 0.41
Free Cash Flow Yield
5.29%5.67%8.05%8.47%9.18%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
162.92 73.48 56.34 24.18 20.76
Price-to-Sales (P/S) Ratio
6.52 5.58 5.04 4.93 4.26
Price-to-Book (P/B) Ratio
-147.63 94.54 26.45 16.59 15.55
Price-to-Free Cash Flow (P/FCF) Ratio
18.91 17.63 12.42 11.80 10.90
Price-to-Operating Cash Flow Ratio
18.70 16.72 12.00 11.47 10.52
Price-to-Earnings Growth (PEG) Ratio
-4.41 -6.08 -0.96 9.22 0.15
Price-to-Fair Value
-147.63 94.54 26.45 16.59 15.55
Enterprise Value Multiple
35.53 25.26 18.52 10.83 10.84
Enterprise Value
452.04B 376.67B 320.56B 340.28B 306.60B
EV to EBITDA
35.53 25.26 18.52 10.83 10.84
EV to Sales
7.58 6.69 5.90 5.86 5.46
EV to Free Cash Flow
21.98 21.12 14.53 14.03 13.94
EV to Operating Cash Flow
21.67 20.03 14.04 13.64 13.46
Tangible Book Value Per Share
-52.22 -51.81 -43.84 -46.48 -52.48
Shareholders’ Equity Per Share
-1.49 1.88 5.86 9.74 8.71
Tax and Other Ratios
Effective Tax Rate
-0.44 -0.15 0.22 0.12 0.11
Revenue Per Share
33.66 31.85 30.72 32.78 31.75
Net Income Per Share
1.35 2.42 2.75 6.68 6.52
Tax Burden
1.44 1.15 0.78 0.88 0.89
Interest Burden
0.37 0.57 0.73 0.86 0.84
Research & Development to Revenue
0.22 0.23 0.16 0.11 0.13
SG&A to Revenue
0.01 0.20 0.20 0.23 0.18
Stock-Based Compensation to Revenue
0.02 0.02 0.01 0.01 0.01
Income Quality
3.11 4.39 4.74 2.11 1.97
Currency in USD